GEOGRAPHIC DIFFERENCES IN THE COMBINED-MODALITY TREATMENT OF STAGE III UNRESECTABLE NON-SMALL CELL LUNG CANCER: RESULTS FROM A GLOBAL PHASE III TRIAL OF TECEMOTIDE (L-BLP25)
JOURNAL OF THORACIC ONCOLOGY（2013）
关键词
tecemotide,non-small cell lung cancer,immunotherapy,START
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要